Q

Quoin Pharmaceuticals Ltd
NASDAQ:QNRX

Watchlist Manager
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Watchlist
Price: 0.585 USD -5.65% Market Closed
Market Cap: 3m USD
Have any thoughts about
Quoin Pharmaceuticals Ltd?
Write Note

Quoin Pharmaceuticals Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Quoin Pharmaceuticals Ltd
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Q
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Cash from Financing Activities
$4.7m
CAGR 3-Years
13%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Compugen Ltd
NASDAQ:CGEN
Cash from Financing Activities
$2.3m
CAGR 3-Years
36%
CAGR 5-Years
-32%
CAGR 10-Years
-31%
B
Biolight Life Sciences Ltd
TASE:BOLT
Cash from Financing Activities
â‚Ş197k
CAGR 3-Years
-65%
CAGR 5-Years
N/A
CAGR 10-Years
-41%
No Stocks Found

Quoin Pharmaceuticals Ltd
Glance View

Market Cap
3m USD
Industry
Life Sciences Tools & Services

Quoin Pharmaceuticals Ltd. is a specialty pharmaceutical company engaged in the development of therapeutic products for the treatment of rare and orphan diseases. The Company’s first lead product is QRX003, a once daily, topical lotion comprised of a broad-spectrum serine protease inhibitor, formulated with the proprietary Invisicare technology, to treat Netherton Syndrome. The product going to be developed for other rare dermatological diseases including Peeling Skin Syndrome, SAM Syndrome, and Palmoplantar Keratoderma. Quoin is also developing QRX004 as a potential treatment for Dystrophic Epidermolysis Bullosa, and QRX006 as a potential therapy for an, as of yet, undisclosed rare skin disease.

QNRX Intrinsic Value
2.695 USD
Undervaluation 78%
Intrinsic Value
Price
Q

See Also

What is Quoin Pharmaceuticals Ltd's Cash from Financing Activities?
Cash from Financing Activities
4.7m USD

Based on the financial report for Jun 30, 2024, Quoin Pharmaceuticals Ltd's Cash from Financing Activities amounts to 4.7m USD.

What is Quoin Pharmaceuticals Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-6%

Over the last year, the Cash from Financing Activities growth was -76%. The average annual Cash from Financing Activities growth rates for Quoin Pharmaceuticals Ltd have been 13% over the past three years , -6% over the past five years .

Back to Top